Citius pharmaceuticals to participate in h.c. wainwright and sidoti investor conferences in september 2023

Cranford, n.j. , sept. 6, 2023 /prnewswire/ -- citius pharmaceuticals, inc. ("citius" or the "company") (nasdaq: ctxr), a late-stage biopharmaceutical company dedicated to the development and commercialization of first-in-class critical care products, today announced its participation in two investor conferences in september 2023.

CTXR Ratings Summary

CTXR Quant Ranking